JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111937200 on December 21, 2001

J. Biol. Chem., Vol. 277, Issue 10, 7897-7904, March 8, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/10/7897    most recent
M111937200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mueller, S.
Right arrow Articles by Wimmer, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mueller, S.
Right arrow Articles by Wimmer, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Interaction of the Poliovirus Receptor CD155 with the Dynein Light Chain Tctex-1 and Its Implication for Poliovirus Pathogenesis*

Steffen MuellerDagger, Xuemei Cao§, Reinhold Welker, and Eckard Wimmer

From the Department of Molecular Genetics and Microbiology, State University of New York, Stony Brook, New York 11794

Received for publication, December 14, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The cellular receptor for poliovirus CD155 (or PVR) is the founding member of a new class of membrane-associated immunoglobulin-like proteins, which include the mouse tumor-associated antigen E4 (Tage4) and three proteins termed "nectins." Using a yeast two-hybrid screen we have discovered that the cytoplasmic domain of CD155 associates strongly and specifically with Tctex-1, a light chain of the dynein motor complex, the latter representing the major driving force for retrograde transport of endocytic vesicles and membranous organelles. We confirmed the interaction biochemically and by co-immunoprecipitation, and we mapped the Tctex-1 binding site to a SKCSR motif within the juxtamembrane region of CD155. Tctex-1 immunoreactivity was detected in mouse sciatic nerve and spinal cord (two tissues of central importance for poliovirus pathogenesis) in punctate, possibly vesicular, patterns. We propose that the cytoplasmic domain may target CD155-containing endocytic vesicles to the microtubular network.

Neurotropic viruses like poliovirus, herpesvirus, rabies virus, and pseudorabies virus all utilize neuronal retrograde transport to invade the central nervous system. Association with Tctex-1 and, hence, with the dynein motor complex may offer an explanation for how poliovirus hijacks the cellular transport machinery to retrogradely ascend along the axon to the neuronal cell body.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Poliovirus, a member of the genus Enterovirus of Picornaviridae, is a human neurotropic virus that causes poliomyelitis, a disease leading to paralysis or death. Although discovered nearly one hundred years ago, the mechanism by which poliovirus invades the central nervous system (CNS)1 and specifically selects motor neurons for destruction remains elusive. Paralytic poliomyelitis is a rare neurologic complication of poliovirus infection (one out of one hundred), as the virus enters humans by ingestion and proliferates largely unnoticed in the gastrointestinal tract. Interestingly, once in the CNS, the virus spares most cells of the CNS parenchyma other than motor neurons from destruction. This unique neurotropism has attracted attention for decades, but no satisfactory explanation has been presented.

A major determinant of a virus' pathogenicity is its tissue tropism, which is governed predominantly by the cognate cell surface receptor. The receptor for all three serotypes of poliovirus, CD155 (also known as PVR), is a membrane-associated, single-span glycoprotein belonging to the immunoglobulin superfamily (1). The CD155 gene expresses four splice variants of which two are membrane-bound (CD155alpha and delta ) and function as poliovirus receptors. CD155beta and gamma  are secreted isoforms lacking a transmembrane domain (2).

Impaired by the apparently exclusive restriction to primates, CD155 is only slowly revealing its physiological functions. CD155 mRNA expression has been detected by Northern blot analyses in brain, small intestine, placenta, heart, skeletal muscle, kidney, lung, and liver (3, 4). Similar albeit not identical expression patterns have been found in transgenic mice expressing the human CD155 gene (5, 6). CD155-tg mice are now well established as a model of human poliomyelitis. Activity of the CD155 promoter in the notochord and floor plate of the developing neural tube of CD155 promoter/LacZ-tg mice suggests that a primary function of CD155 may relate to the development of the CNS during embryogenesis (7).

The sites of primary infection and gastroenteric replication of poliovirus are thought to be in tonsillopharyngeal tissue and the Peyer's patches of the small intestine (8, 9). The commonality between these structures is their large concentration of lymphatic cells, but, remarkably, the predominant cells supporting poliovirus proliferation in the gastrointestinal tract of an infected individual remain unknown.

As aforementioned, poliovirus infections are mainly restricted to the enteric tract. Viremia, however, is a prerequisite for the progression to poliomyelitis. How poliovirus spreads subsequently from the blood to the CNS is poorly understood. Two pathways have been suggested. First, the virus may directly pass from the blood into the CNS by crossing the blood-brain barrier (10). The second hypothesis suggests that the virus is transported by retrograde axonal transport ascending from the muscle to the spinal cord and brain (11). This hypothesis has found strong support in experiments with CD155-tg mice (12-14). The presence of poliovirions in axons during poliomyelitis has been a long observed phenomenon (15, 16). Ohka and colleagues (12) provided direct evidence of poliovirus in the sciatic nerves of tg mice and showed that during retrograde axonal transport the virus remains in the form of an intact 160 S particle.

In this study we have focused on one or more possible functions of the intracellular C-terminal domain of CD155 to decipher cell-internal interactions important for protein function, perhaps related to poliovirus pathogenesis. We have therefore analyzed the C-terminal peptides of CD155alpha and -delta in a yeast two-hybrid screen. Here we describe the interaction of the cytoplasmic domain of CD155 with Tctex-1, a light chain subunit of the dynein motor complex. Considering the function of dynein as the major driving force for minus end-directed transport along microtubuli, we propose that we have identified a molecular link between poliovirus and the retrograde axonal transport machinery. Indeed, we consider it possible that the majority of poliovirus infection of the CNS leading to destruction of motor neurons may occur via retrograde axonal transport. We discuss our results in light of most recent findings for two other neurotropic viruses, rabies and herpesvirus.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials

COS-1 and HEK 293, and HEK 293T cells, were maintained in Dulbecco's modified Eagle's medium (10% fetal bovine serum and penicillin/streptomycin). Two independently derived affinity-purified anti-Tctex-1 polyclonal antibodies were kindly provided by S. King (R5205, University of Connecticut, Farmingville, CT) and K. Campbell (Fox Chase Cancer Center, Philadelphia, PA) (17, 18). Monoclonal antibodies (mAbs) against the intermediate chain of Dynein IC74 (clone 70.1), and against alkaline phosphatase (clone 8B6) were purchased from Sigma Chemical Co. In addition, anti-CD155 mAbs D171 (19) and P44 (A. Nomoto, Tokyo University, Japan) as well as anti-mNectin2 mAb 6B3 (20) were used in this study.

Plasmids

Plasmids were constructed using PCR and standard cloning techniques (21). Two bait constructs for the yeast two-hybrid screen, pLexA-CD155alpha or pLexA-CD155delta , were generated by fusing the coding region of the cytoplasmic domains of either CD155alpha or CD155delta to the LexA DNA-binding domain in the vector pTT38.2 pLexA-lam (S. Fields, University of Washington, Seattle) contains amino acids 66-230 of human lamin C fused to the LexA DNA-binding domain. pcDNA-Tctex-1 was generated by recovering the entire EcoRI-XhoI Tctex-1 cDNA insert of clone pCW-1 isolated in the two-hybrid screen (GenBankTM accession number U56255) and inserting it into the pCDNA3.1 vector (Invitrogen). pCDNA-CD155(AO) (G. Bernhardt, Max-Dellbrück Center für Molekulare Medizin, Berlin, Germany) contains the entire CD155alpha cDNA. For generation of GST fusion constructs pGEX-CD155alpha -cyt and pGEX-Tctex-1, the cytoplasmic domain of CD155alpha or the entire Tctex-1 coding region was inserted into pGEX-KG (22). A mutant pGEX-CD155alpha -cm, harboring two amino acid changes (K369T, R372L; see Fig. 1) was generated by site-directed mutagenesis from pGEX-CD155alpha -cyt. For pCDNA-AP-CD155alpha -cyt, the coding region of human secreted alkaline phosphatase (SEAP) was recovered from pAPtag4 (J. Flanegan, Harvard University, Cambridge, MA), inserted into pCDNA3.1, and fused to the cytoplasmic domain of CD155alpha .


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic representation of the CD155 molecules. Three extracellular immunoglobulin-like domains (circles) are formed by disulfide bonds. The transmembrane domain (box) and the potential extracellular glycosylation sites (N) are shown. Amino acid sequences of the cytoplasmic domains of CD155alpha (CD155alpha -cyt), CD155delta (CD155delta -cyt), and a CD155alpha double mutant (CD155alpha -cm) are listed at the bottom. The identical amino acid sequence between cytoplasmic domains of CD155alpha and CD155delta are indicated by dashes. Numbers indicate the amino acid position with respect to the CD155alpha protein sequence.

Yeast Two-hybrid Screen

An HeLa cell cDNA library constructed in pGAD-GH (23) was used. The yeast tester strain L40 (24) was co-transformed with the cDNA library and either plasmid pLexA-CD155alpha or pLexA-CD155delta and plated onto selection plates, lacking His, Leu, and Trp. Primary positive colonies were replated and tested for LacZ expression by filter binding assay. Prey plasmids of His+/LacZ+ colonies were recovered, transformed into E. coli, and sequenced. The level of interaction of the most strongly positive clone, pCW-1, was determined by beta -galactosidase liquid assay.

In Vitro Binding Experiments

GST fusion proteins were expressed and purified as previously described (25). 35S-Labeled Tctex-1 protein was generated from plasmid pCDNA-Tctex-1 using the coupled wheat germ in vitro transcription/translation system (TnT by Promega) according to the manufacturer's instructions. 100 µg of GST fusion protein loaded to beads was incubated with 20 µl of translation product for 30 min at 30 °C, agitating the mixture every 2-3 min, followed by four washes with binding buffer. Bound proteins were separated by SDS-PAGE gel and visualized by autoradiography.

In a second type of GST pull-down experiment, a cytoplasmic cell lysate of the mouse neuroblastoma cell line Neuro2A was used as a source of endogenous Tctex-1. Neuro2A cells were lysed in cold lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% Nonidet P-40, 0.1% deoxycholate, 10% glycerol) containing protease inhibitors. An equivalent of 5 × 106 cells was incubated with 50 µg of GST fusion protein on beads for 3 h at 4 °C under agitation. Beads were washed three times with lysis buffer, followed by SDS-PAGE of the eluted proteins and Western blotting with rabbit polyclonal antibody R5205 against Tctex-1.

In a third pull-down strategy we combined the efficacy of the GST system with the convenience of detection of AP fusion proteins. Plasmid pCDNA-AP-CD155alpha -cyt or SEAP expression plasmid pAPtag4 were transfected into HEK 293 cells. One milliliter of conditioned medium (containing 1500A405nm/ml/h of AP fusion proteins) was incubated with 100 µg of GST fusion proteins bound to beads and agitated for 2 h at room temperature. The beads were then washed four times with PBS, and the amount of AP protein that was bound to the beads was determined using 9 mg/ml p-nitrophenyl phosphate (in 1 M diethanolamine, pH 9.8, 0.5 mM MgCl2) as a colorimetric substrate.

Immunological Methods

Western Blotting-- For analysis of Tctex-1 protein expression, lysates of mouse tissues from adult ICR mice were prepared by sonification. Equal amounts of protein were separated by SDS-PAGE and blotted onto nitrocellulose membranes (Schleicher & Schuell) followed by Western blot analysis with anti-Tctex-1 antibodies. Intensity of Tctex-1-immunoreactive bands on the exposed film was determined by pixel count analysis of the scanned image with IMAGE 1.61 software (National Institutes of Health).

Co-immunoprecipitation-- HEK 293T cells were co-transfected with CaPO4 precipitates of plasmids pCDNA-Tctex-1 and pCDNA- CD155(AO). Three days following transfection, cells were lysed and processed as described above for Neuro2A cells. The lysate of 5 × 106 cells was incubated with anti-dynein (IC74) antibody 70.1, a control IgG antibody (anti-mNectin-2, clone 6B3), or anti-CD155 antibodies (D171 and P44). Immune complexes we captured by the addition of Protein A/G Plus-agarose beads (Santa Cruz Biotechnologies). The precipitated proteins were analyzed by Western blotting using anti-Tctex-1 antibodies.

Immunofluorescence-- Fresh, unfixed mouse lumbar spinal cord and sciatic nerve tissues were frozen in O.C.T. cryoprotectant (Tissue-Tek). E13.5 mouse embryos were fixed for 2 h in 4% paraformaldehyde before cryoprotection. Frozen sections were collected on poly-L-lysine-coated slides, air-dried, and fixed in cold 1:1 methanol/acetone for 90 min at -20 °C. Sections were blocked with PBS containing 5% normal horse and 2% normal goat serum for 2 h at room temperature, followed by overnight incubation at 4 °C with anti-Tctex-1 antibodies (17) at a dilution of 1:200 in blocking buffer. After 2 h of washing with PBS, the sections were incubated with a 1:500 dilution of Cy3-conjugated anti-rabbit antibody (Jackson ImmunoResearch) for 1 h at 37 °C. The sections were washed for 2 h in PBS and mounted with Immu-Mount (Shandon, Pittsburgh, PA). Images were acquired on a Zeiss Axioplan II fluorescence microscope equipped with a model SP401 camera (Diagnostic Instruments Inc.) and processed with Adobe Photoshop software.

Northern Blot Analysis of Tctex-1 Expression

Multiple tissue Northern blots were purchased from CLONTECH. The blots were hybridized at 55 °C for 16 h with 32P-labeled probes, made from a DNA fragment containing the complete CW-1 (Tctex-1) sequence (nucleotides 1-713) by the random primed DNA labeling system (Invitrogen).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Isolation of CD155-binding Proteins-- To identify cytoplasmic proteins that interact with CD155, the intracellular domains of CD155alpha and CD155delta were used as baits in a yeast two-hybrid screening procedure similar to that originally described (26, 27). The majority of His+ colonies showed LacZ activity, expressing different levels of beta -galactosidase, as assessed by filter binding assay (data not shown). Four classes of strongly to weakly lacZ-expressing clones were isolated. One group of most strongly positive cDNA clones, termed pCW-1, was isolated from yeast and co-transformed with the plasmid pLexA-CD155alpha or pLexA-CD155delta . pCW-1 conferred resistance to His- selection only when co-transformed with pLexA-CD155alpha or pLexA-CD155delta but not with a control plasmid, pLex-lam (Fig. 2).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 2.   Two-hybrid screen with cytoplasmic domains of CD155. Yeast strain L40 (24) containing plasmid expressing the Gal4 activation domain-Tctex-1 fusion in combination with plasmid expressing a LexA DNA-binding domain fused to either the cytoplasmic domain of CD155alpha (a), the cytoplasmic domain of CD155delta (b), or the coding sequence of lamin (c). His+, the plate that lacks only leucine and tryptophan and thus selects only for the presence of the activation domain and DNA-binding domain containing plasmids. His-, the plate that lacks Leu, Trp, and His, thus selects not only for the presence of the two plasmids but also for the interaction of the two plasmid-encoded fusion proteins.

As shown in Table I, beta -galactosidase activity was detected only in yeast in which plasmids pCW-1 and pLexA-CD155alpha or pLexA-CD155delta were co-expressed. There was no activity with either Gal4 or LexA-expressing plasmids, both plasmids together, or when co-transformed with pCW-1 and pLexA-lam. About 2000 units of beta -galactosidase activity were produced when the cytoplasmic domains of CD155 and full-length CW1 (Tctex-1, see below) were provided (Table I). This indicated that there is a strong interaction between the cytoplasmic domains of either CD155alpha or CD155delta and the CW-1 fusion protein expressed in this yeast two-hybrid system.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Activation of LacZ reporter gene by Gal4 chimeras
Values for beta -galactosidase activity (Miller units) are the mean of assays on at least five transformants, each assayed at least twice.

CW-1 Is the Human Homolog to the tctex-1 Gene of the Mouse t Complex, a Subunit of Dynein-- Sequence analysis of the clone pCW-1 revealed a fragment of ~710 bp fused to the Gal4 transcriptional activation domain. The predicted open reading frame (ORF) was 339 nucleotides long. DNA sequences of 10 individual cDNA clones of pCW-1 were analyzed. All cDNA clones corresponded to the same gene (our GenBankTM accession number U56255), which upon BLAST search was found to be highly homologous to the product of the mouse tctex-1 (t complex testis expressed-1) gene (28). CW-1 and mouse Tctex-1 share ~88% nucleotide identity and ~94% amino acid identity along their respective ORFs. While this study was ongoing Watanabe et al. (29) also cloned the human homolog of mouse Tctex-1, identical to our sequence, and named it TCTEL1. We will continue to use the original designation Tctex-1 for the human protein throughout this report.

Subsequently, Tctex-1 was identified as a light-chain subunit of the dynein motor complex (18, 30). Dynein exists in two isoforms. Cytoplasmic dynein represents the major driving force of retrograde transport of membrane-bound organelles and vesicles and is involved in spindle movement during mitosis. Axonemal dynein, on the other hand, is the force generator responsible for flagellar and ciliary beating, as is observed in the flagella of sperm or the cilia of the respiratory tract epithelium. Tctex-1 was found to be present in both forms of dynein (18, 30).

Tctex-1 Expression in Mouse and Human Tissues-- Except for the overexpression of Tctex-1 mRNA in t-haplotype mice (28), little information is available regarding the expression profile of Tctex-1, particularly in humans. We, therefore, performed Northern blot analysis to determine the expression of the Tctex-1 mRNA in human tissues. A radiolabeled DNA probe corresponding to the entire Tctex-1 cDNA detected a single 0.75- to 0.8-kb band in all tissues tested (Fig. 3A). The highest expression of Tctex-1 was observed in skeletal muscle and testis (Fig. 3A, lanes 6 and 12), whereas the lowest expression was seen in brain and thymus (lanes 2 and 10). This expression pattern matches that observed in mouse and rat (28, 31).


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 3.   Analysis of Tctex-1 expression in human and mouse tissues. A, human multiple tissue Northern blot (CLONTECH). A single band of 750-800 nucleotides was detected by hybridization with a 32P-DNA probe encompassing the entire Tctex-1 cDNA, which was labeled by random priming. The sources of human RNAs are as indicated. PBL, peripheral blood leukocytes. B, expression profile of Tctex-1 protein in mouse tissues. Tctex-1 Western blot analysis was performed on tissue lysates of the indicated origins. Approximately 100 µg of total protein was loaded per lane.

Because CD155-tg mice are a widely used model for the study of poliomyelitis, we were interested in whether tissue-specific patterns in the expression level of Tctex-1 protein reveal similarities to the patterns observed by Northern blot analyses. For this purpose we prepared whole tissue lysates (see "Experimental Procedures") and analyzed mouse Tctex-1 protein expression by Western blotting. Tctex-1 protein could be detected in all tissues tested, albeit at differing amounts. Protein levels in mouse tissues largely agreed with the mRNA expression in humans (Fig. 3). Especially the high expression in testis (Fig. 3B, lane 7) and low expression in CNS (lanes 1-3) and liver (lane 6) confirm previously reported results (28, 31). However, the very high levels of Tctex-1 mRNA expression in skeletal muscle in humans is in disagreement with the low levels of Tctex-1 protein found in mouse skeletal muscle (compare Fig. 3A, lane 6, and Fig. 3B, lane 4). The reason for this discrepancy is not known. In several tissues the anti-Tctex-1 antibodies recognized a doublet of bands. The presence of a second band was most evident in uterus, spleen, and kidney (Fig. 3B, lanes 9-11). Mou and coworkers (32) found Tctex-1 to be phosphorylated by the Src family kinase p59fyn. Different phosphorylation states may therefore account for the variable apparent size of Tctex-1. The identity of the 20-kDa band in stomach tissue remains unknown (Fig. 3B, lane 12).

We next examined by indirect immunofluorescence the expression of Tctex-1 in mouse tissues most relevant to poliovirus pathogenesis, sciatic nerve, and lumbar spinal cord. Using an affinity-purified rabbit polyclonal antibody (17) in combination with a Cy3-conjugated anti-rabbit secondary antibody, we detected Tctex-1 protein in both spinal cord and sciatic nerve (Figs. 4, and 5, respectively). Tctex-1 immune reactivity was higher in embryonal spinal cord and dorsal root ganglia (E13.5; Fig. 4E) when compared with the adult (Fig. 4A). This is in agreement with the developmental regulation of Tctex-1 mRNA expression in CNS and other tissues that has been described by DiBella and colleagues (33). Among a variety of neuronal cell bodies, Tctex-1 was also expressed in the notably large motor neurons of the anterior horn (Fig. 4C, arrows). Tctex-1 staining was largely confined to small punctae of homogenous size (Fig. 4C, and inset). This punctate staining was also observed in the dorsal root where it appeared to be localized along linear tracts, an observation suggesting that it might be associated with sensory nerve fibers (Fig. 4D). A similar Tctex-1 distribution was found in sciatic nerve (Fig. 5). It should be noted that two independently derived Tctex-1 antisera, whose specificity has been demonstrated previously (17, 18), gave identical staining patterns (data not shown). We consider it likely that Tctex-1 may be present in transport vesicles, a conclusion supported by the findings of the groups of Chao and Sung who independently showed the presence of Tctex-1 in axons of cultured neurons (34) and within synaptic vesicles at mossy fiber terminals (35).


View larger version (148K):
[in this window]
[in a new window]
 
Fig. 4.   Localization of Tctex-1 in mouse spinal cord by indirect immunofluorescence analysis. A, C, D, and E represent Tctex-1 immune reactivity using affinity-purified rabbit anti-Tctex-1 antibody (17). B, no staining was observed with an unrelated rabbit preimmune serum. A and B, adult spinal cord (right hemichord). Note: Each image is a composite of two frames taken with a ×10 objective. C, higher magnification of boxed area in A. Two motor neurons are marked by arrows. The inset depicts a motor neuron with Tctex-1 immune reactivity localizing to small punctae. D, adult dorsal root at the region of the dorsal root entry zone. Tctex-1 punctate staining is found concentrated along linear tracts. E, embryonic spinal cord and dorsal root ganglia (E13.5). VH, ventral horn; DH, dorasl horn; MN, motor neuron; DRG, dorsal root ganglion. Scale bars: A, B, and E, 200 µm; C, 100 µm; C (inset) and D, 20 µm.


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 5.   Localization of Tctex-1 in mouse sciatic nerve. A-C, longitudinal sections of adult mouse sciatic nerve. A, Tctex-1 immunoreactivity is found throughout the sciatic nerve, in patterns reminiscent of fiber tracts. B, higher magnification of boxed area in A. C, no staining was observed with an unrelated rabbit preimmune serum. Scale bars: A and C, 200 µm; B, 100 µm.

Analysis of the CD155-Tctex-1 Interaction in Vitro-- To confirm the interaction of CD155 with Tctex-1, we generated and expressed in E. coli fusion proteins between glutathione S-transferase (GST) and Tctex-1 or the intracellular C-terminal portion of CD155alpha (GST-CD155alpha -cyt, Fig. 6A). In a first set of experiments, the GST fusion proteins, bound to glutathione-Sepharose beads, were then used in a GST pull-down assay (36) to determine affinities to in vitro translated 35S-Tctex-1. GST-CD155alpha -cyt specifically bound Tctex-1 (Fig. 6B, lane 4), whereas GST alone did not interact with Tctex-1 (lane 2). We also noticed a weak homo-interaction of Tctex-1 with GST-Tctex-1 (lane 3), an observation supporting a recent report by DiBella and co-workers (33) who demonstrated that Tctex-1 may form a homodimer within the dynein complex.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 6.   CD155/Tctex-1 interaction demonstrated by GST pull-down assay. A, SDS-PAGE analysis of purified GST fusion proteins (Coomassie Blue-stained). Lane 1, GST; lane 2; Tctex-1 fused to GST; lane 3, K369T/R372L double mutant of CD155alpha fused to GST; lane 4, wild type cytoplasmic domain of CD155alpha fused to GST. B, GST pull-down of radiolabeled Tctex-1 protein, synthesized by in vitro translation. GST fusion proteins bound to glutathione beads were incubated with 20 µl of in vitro translated Tctex-1. The beads were analyzed for specifically bound Tctex-1 by SDS-PAGE followed by autoradiography. Lane 1, 5 µl of Tctex-1 in vitro translation reaction; lanes 2-4, Tctex-1 protein recovered by binding to GST fusion proteins, as indicated. C, GST pull-down of endogenous Tctex-1. Mouse Neuro2A cell lysates were incubated with the indicated GST fusion proteins or empty glutathione beads. Proteins bound to the beads were separated by SDS-PAGE and analyzed by Tctex-1 Western blot (middle panel). The intensities of Tctex-1-immunoreactive bands on the image of the scanned x-ray film were determined using the National Institutes of Health IMAGE software (lower panel). The numbers represent a pixel count for each lane. The top portion of the same gel was Coomassie-stained as a loading control for the GST fusion proteins (top panel).

To ascertain whether CD155alpha could also interact with endogenous Tctex-1 present in neuronal cells, we extended the GST pull-down experiments and replaced Tctex-1 radiolabeled by in vitro translation with Tctex-1 from cytoplasmic lysates of mouse Neuro2A cells (Fig. 6C). The material bound to the glutathione beads was analyzed for the presence of Tctex-1 protein by immunoblotting. As is apparent in Fig. 6C, CD155alpha strongly interacted with cellular Tctex-1 (middle panel, lane 5). Neither glutathione beads alone, nor GST complexed to glutathione beads, interacted with endogenous Tctex-1 under the conditions of the assay (lanes 2 and 3, respectively). Because both membrane-bound splice variants of CD155, CD155alpha , and CD155delta , interacted with Tctex-1 in the two-hybrid system, we suspected that the target sequence for Tctex-1 binding lay within the 17 N-terminal cytoplasmic residues that both splice variants have in common (see Fig. 1B). Mok and colleagues (37) have proposed the sequence (R/K)(R/K)XX(R/K) as a Tctex-1 consensus recognition motif . The N-terminal portions of both CD155 cytoplasmic domains contain the sequence SKCSR, which partly matches this motif (Fig. 1B). We therefore produced a CD155alpha mutant protein (CD155alpha -cm) in which the SKCSR sequence was changed to STCSL (bold residues represent those that have been mutated. Binding of CD155alpha -cm to Tctex-1 was reduced by more than 10-fold when compared with the wild type protein (Fig. 6, middle panel, compare lanes 4 and 5). This observation strongly suggests that the SKCSR sequence, indeed, is critical for the interaction between CD155 and Tctex-1.

We then developed a different assay in which we combined the GST system with the ease of detection of alkaline phosphatase-tagged proteins. The cytoplasmic domain of CD155alpha was fused to the C terminus of human placental secreted alkaline phosphatase (AP-CD155alpha -cyt, Fig. 7A). AP-CD155alpha -cyt fusion protein and untagged AP protein were expressed in HEK 293 cells from which they were secreted into the culture medium of the cells. After 5 days of expression the medium contained ~1500 A405 nm/ml/h of alkaline phosphatase activity, as assessed by a colorimetric assay using p-nitrophenyl phosphate as a substrate for alkaline phosphatase (see "Experimental Procedures"). To confirm the integrity of the secreted proteins, we immunoprecipitated the AP proteins from the supernatant with an alkaline phosphatase-specific antibody and analyzed the immune complexes by Western blot using the same antibody (Fig. 7B). As expected, AP-CD155alpha -cyt appeared to be slightly larger than AP, due to the addition of 50 amino acids comprising the cytoplasmic domain of CD155alpha (Fig. 7B, lane 2). The secreted AP and AP-CD155alpha -cyt were then incubated with glutathione beads to which GST fusion proteins were bound. Although none of the GST fusion proteins bound any significant amount of untagged AP protein (Fig. 7, bars 2, 4, 6), GST-Tctex-1-loaded beads specifically captured AP-CD155alpha -cyt from the medium (bar 1). No interaction was seen between AP-CD155alpha -cyt and GST alone (bar 5). Finally, under the conditions of the assay, there was also no homo-interaction observed between CD155 cytoplasmic tails, because we detected no signal after incubation of AP-CD155alpha -cyt with GST-CD155alpha -cyt (bar 3).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 7.   Tctex-1 interaction with a CD155-alkaline phosphatase fusion protein. A, the cytoplasmic domain of CD155alpha was fused to the SEAP ORF, to produce AP-CD155alpha -cyt. B, AP and AP-CD155alpha -cyt proteins were expressed in HEK 293 cells and secreted into the culture medium. Immunoprecipitation of 0.5 ml of conditioned culture medium with alkaline phosphatase-specific antibodies followed by anti-alkaline phosphatase Western blotting produced single immune-reactive bands of 67 and 71 kDa, respectively (lanes 1 and 2). C, the supernatants containing the expressed proteins were used as probes for GST pull-down. If an interaction occurred, alkaline phosphatase activity could be recovered from the glutathione beads. The amount of bound AP fusion protein was assayed in a colorimetric assay using p-nitrophenyl phosphate as a substrate. Absorbance was read at 405 nm.

CD155 and Tctex-1 Interact in Vivo-- To test whether an association between CD155 and Tctex-1 could be observed in tissue culture cells, we performed co-immunoprecipitation experiments. HEK 293T cells were co-transfected with expression plasmids for CD155 and Tctex-1. Cell lysates were subjected to immunoprecipitation using anti-dynein IC74 mAb 70.l (Fig. 8, lane 2), an unrelated IgG control antibody (lane 3), or a mix of monoclonal anti-CD155 antibodies D171 and P44 (lane 4). Immune complexes were resolved by SDS-PAGE and analyzed for Tctex-1 by Western blot analysis. As expected, antibody 70.1, directed against the intermediate chain of dynein, co-precipitated Tctex-1 (Fig. 8, lane 2), which is a light-chain subunit of dynein and is thought to interact directly with the intermediate chain (31, 37). An IgG control antibody, directed against mouse Nectin 2 (which is not expressed on human cells), did not precipitate any Tctex-1 protein (Fig. 8, lane 3). However, when incubated with anti-CD155 antibodies D171 and P44, Tctex-1 protein could be precipitated from the cell lysate (Fig. 8, lane 4). This observation indicated that CD155 and Tctex-1 also interacted specifically in intact cells.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 8.   Co-immunoprecipitation of CD155 and Tctex-1. HEK 293T cells were co-transfected with expression plasmids for full-length CD155 and Tctex-1. Cell lysates were incubated with precipitating antibodies as indicated. The co-immunoprecipitate was recovered by protein A/G beads and analyzed by 13.5% SDS-PAGE followed by anti Tctex-1 Western blot. Lane 1, cell lysate; lane 2, immunoprecipitation (IP) with anti-dynein IC74 mAb; lane 3, IP with an unrelated IgG mAb; lane 4, IP with anti-CD155 mAbs D171/P44. The protein band corresponding to Tctex-1 protein is marked by an arrow.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this study we have described the interaction between the cytoplasmic domain of the poliovirus receptor CD155 and Tctex-1, an association that we originally detected in a yeast-hybrid screen. We have presented evidence for the authenticity of this interaction by four independent biochemical and immunological assays in vitro and in intact cells. Our data indicate that Tctex-1 interacts with an SKCSR motif in the juxtamembrane region of the cytoplasmic domain of CD155. We have, furthermore, presented evidence of the presence of Tctex-1 protein in neurons of the spinal cord, particularly motor neurons, and along fiber tracts within the dorsal root and the sciatic nerve. The specific interaction between CD155 and Tctex-1 can serve to explain an enduring conundrum: How does poliovirus reach motor neurons, its targets in the CNS, via retrograde axonal transport?

Tctex-1 was originally identified as a candidate gene responsible for transmission ratio distortion in male t-haplotype mice (28) and has subsequently been shown to be a subunit of the cytoplasmic and axonemal dynein complex (18, 38). Dynein ATPases are molecular motors that translocate along microtubules thereby providing the driving force for a variety of important cellular processes, most prominently the minus end-directed (retrograde) transport of membranous vesicles and organelles, and the motile forces necessary for flagellar and ciliary beating (reviewed in Ref. 39). Once poliovirus infection has progressed to viremia, two pathways are open for virus invasion into the CNS: crossing the blood-brain barrier or retrograde axonal transport following passage through the neuromuscular junction (NMJ). Experimental evidence is sparse for the former but abundant for the latter. Importantly, retrograde axonal transport has been cited as the only explanation for "provocation poliomyelitis," a phenomenon where muscle trauma may predispose an infected person to poliomyelitis (11, 13). Provocation poliomyelitis has also been suggested as the cause for paralytic cases in a historic vaccine accident, known as the "Cutter incidence." Here, children who received intramuscular injections of inadequately inactivated poliovirus vaccine batches developed focal limb paralysis (40). This phenomenon can be replicated in CD155-tg mice: When injected intramuscularly with PV, paralysis almost exclusively develops first in the limb that was inoculated (12-14). In the 1990s, an alarming increase of oral vaccine-associated paralytic poliomyelitis was observed if vaccinees received by coincidence intramuscular injections of, for example, antibiotics or diphtheria-tetanus-pertussis vaccine (41, 42). It was suspected that muscle injury of recipients of the Sabin oral vaccines predisposed vaccinees to vaccine-associated paralytic poliomyelitis. Direct evidence for an increased risk of poliomyelitis following muscle injury was finally provided in experiments with CD155-tg mice (13). Considering that paralysis in most poliomyelitis patients is found in limbs, it is intriguing to speculate that poliovirus pathogenesis may result predominantly from retrograde axonal transport to target motor neurons followed by their destruction.

The mechanism by which muscle injury opens a portal at the NMJ to allow virus entry into the presynaptic motor neuron is unknown. One report describes the expression of CD155 at the NMJ, and its up-regulation in degenerating muscle fibers (43). Such degenerating fibers would likely be present after muscle trauma, which, in turn, could lead to increased poliovirus replication near or at the NMJ favoring CD155 docking and entry into the motor neuron axon. We propose that the CD155-bound virus is then taken up at the nerve terminal into an endocytic vesicle. While the virus remains attached to the receptor, the cytoplasmic tail of CD155 interacts with Tctex-1, the latter mediating retrograde transport of the entire vesicle via the dynein complex to the motor neuron cell body (Fig. 9). Indeed, our evidence of Tctex-1 localization to small punctae within motor neurons and peripheral nerves, reminiscent of membrane-bound organelles, (Figs. 4 and 5), would agree with such a model. This scenario requires the presence of Tctex-1 near the presynaptic membrane where, according to our model, virus uptake would occur. Interestingly, Chuang et al. (35) found Tctex-1 to be concentrated in small pre-synaptic vesicles at axon terminals of subsets of rat hippocampal neurons. Although it has not been directly shown at the subcellular level that Tctex-1 is expressed at motor axon terminals, Mou and colleagues (32) found the protein to be highly enriched in the eletroplax of Torpedo californica, an organ resembling a large specialized neuromuscular junction. Together with our evidence (Fig. 5) and that of others (34) of Tctex-1 immune reactivity within the sciatic nerve, it is plausible to speculate that Tctex-1 may serve a function in retrograde transport from the motor axon terminal to the neuronal cell body. The recent findings of Yano and colleagues (34) lend further support to this hypothesis. This group showed that retrograde axonal transport of neurotrophin receptors (TrkA, B, and C) within the sciatic nerve of rats is facilitated by association of Trk with the dynein motor complex via binding of Tctex-1 (34). Thus, neurotrophins like nerve growth factor appear to remain linked to the dynein motor as a receptor-ligand complex for the duration of transport from the time of uptake at the synapse until they reach the neuronal cell body. This mechanism seems strikingly similar to our proposed model of poliovirus retrograde axonal transport. Sung and colleagues (44) have recently provided convincing evidence that the Tctex-1-containing subpool of cytoplasmic dynein is involved in apical transport of rhodopsin in polarized epithelial cells. Apical transport in polarized cells and retrograde axonal transport in the ultimately polarized cell, the motor neuron, are both minus end-directed processes that are analogous in many ways (reviewed in Ref. 45).


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 9.   Proposed model of CNS invasion by poliovirus. 1, following virus replication in muscle, virions are released near or at the NMJ, and taken up at the presynaptic membrane of a motor axon by CD155-mediated endocytosis. Muscle injury or inflammatory responses due to the PV infection may facilitate this process by up-regulation of CD155 expression. The virus-receptor complex by interaction with Ttcex-1 is targeted to the microtubular network of the axon. 2, the intact 160S virions complexed to the dynein motor by virtue of CD155 interaction with Tctex-1 are transported along microtubuli by fast retrograde axonal transport. 3, arriving at the motor neuron's cell body, the change in environment from axoplasm to cytoplasm triggers virus uncoating. Viral genomic RNA is released into the cytoplasm, and virus replication ensues, thereby killing the motor neuron. Paralysis of the muscle fiber formerly innervated by this motor neurons follows. Lateral spreading to neighboring spinal motor neurons may occur, which kills those neurons directly and independently of retrograde axonal transport.

It is interesting to note that structural proteins of other neurotropic viruses (herpes, rabies, and Mokola virus) have recently been reported to interact with components of the dynein motor complex (46-48). More intriguing yet is the fact that herpesviruses use as their cellular receptors Nectin-1 and -2, two molecules of the CD155 family of immunoglobulin-like proteins (49, 50). Most promiscuous in terms of receptors is pseudorabies virus (PRV), an animal herpesvirus that can use Nectin-1, Nectin-2, as well as CD155 for cell entry (49, 50). PRV is being used widely as a transneuronal tracer in neuroanatomical studies by virtue of monitoring its retrograde travel from the site of injection along axonal pathways of neurons (51, 52). The P protein of rabies and Mokola virus has been found to bind to the dynein light-chain polypeptide LC8 (46, 47). Indeed, CD155 as well as acetylcholine receptor, a putative receptor for rabies virus, are expressed at the NMJ (43, 53). Just as in provocation poliomyelitis, rabies virus pathogenesis is mostly preceded by muscle trauma (here, the bite of a rabid animal) with subsequent virus entry into axons and retrograde transport to neuronal targets (54).

It appears that the underlying mechanisms of CNS invasion for all three groups of viruses, poliovirus, lyssaviruses (e.g. rabies), and herpesviruses (herpes simplex virus, PRV), are similar by hijacking the dynein machinery for retrograde travel to target neurons.

    ACKNOWLEDGEMENTS

We are grateful to Drs. Steve King, Kerry Campbell, Akio Nomoto, and Günter Bernhardt for antibodies and plasmids. We are indebted to Meijia Yang and Stan Fields for valuable discussion and suggestions as well as for providing us the materials of yeast two-hybrid system.

    FOOTNOTES

* This work was supported in part by Public Health Service Grants A1-15122 and R01AT-32100 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported by a doctoral fellowship of Boehringer Ingelheim Fonds, Heidesheim, Germany.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) U56255.

§ Current address: Pfizer Global Research & Development, Groton, CT 06340.

To whom correspondence should be addressed: Dept. of Molecular Genetics and Microbiology, State University of New York, Stony Brook, NY 11794. Tel.: 631-632-8787; Fax: 631-632-8891; E-mail: ewimmer@ms.cc.sunysb.ed.

Published, JBC Papers in Press, December 21, 2001, DOI 10.1074/jbc.M111937200

2 M. Yang, unpublished.

    ABBREVIATIONS

The abbreviations used are: CNS, central nervous system; mAb, monoclonal antibody; GST, glutathione S-transferase; AP, alkaline phosphatase; SEAP, secreted alkaline phosphatase; ORF, open reading frame; NMJ, neuromuscular junction; PRV, pseudorabies virus.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Mendelsohn, C. L., Wimmer, E., and Racaniello, V. R. (1989) Cell 56, 855-865[CrossRef][Medline] [Order article via Infotrieve]
2. Koike, S., Horie, H., Ise, I., Okitsu, A., Yoshida, M., Iizuka, N., Takeuchi, K., Takegami, T., and Nomoto, A. (1990) EMBO J. 9, 3217-3224[Medline] [Order article via Infotrieve]
3. Ren, R., and Racaniello, V. R. (1992) J. Virol. 66, 296-304[Abstract/Free Full Text]
4. Koike, S., Aoki, J., and Nomoto, A. (1994) in Cellular Receptors for Animal Viruses (Wimmer, E., ed) , pp. 463-480, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
5. Koike, S., Taya, C., Kurata, T., Abe, S., Ise, I., Yonekawa, H., and Nomoto, A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 951-955[Abstract/Free Full Text]
6. Ren, R., Costantini, F., Gorgacz, E. J., Lee, J. J., and Racaniello, V. R. (1990) Cell 63, 353-362[CrossRef][Medline] [Order article via Infotrieve]
7. Gromeier, M., Solecki, D., Patel, D. D., and Wimmer, E. (2000) Virology 273, 248-257[CrossRef][Medline] [Order article via Infotrieve]
8. Bodian, D. (1956) Am. J. Hyg. 64, 181-197[Medline] [Order article via Infotrieve]
9. Sabin, A., and Ward, R. (1941) J. Exp. Med. 73, 757-770[Abstract]
10. Yang, W. X., Terasaki, T., Shiroki, K., Ohka, S., Aoki, J., Tanabe, S., Nomura, T., Terada, E., Sugiyama, Y., and Nomoto, A. (1997) Virology 229, 421-428[CrossRef][Medline] [Order article via Infotrieve]
11. McCloskey, B. P. (1950) Lancet 1, 659-663[CrossRef]
12. Ohka, S., Yang, W. X., Terada, E., Iwasaki, K., and Nomoto, A. (1998) Virology 250, 67-75[CrossRef][Medline] [Order article via Infotrieve]
13. Gromeier, M., and Wimmer, E. (1998) J. Virol. 72, 5056-5060[Abstract/Free Full Text]
14. Ren, R., and Racaniello, V. R. (1992) J. Infect. Dis. 166, 747-752[Medline] [Order article via Infotrieve]
15. Bodian, D. (1940) Brain 63, 135-177[Free Full Text]
16. Fairbrother, R. W., and Hurst, E. W. (1930) J. Pathol. Bacteriol. 33, 17-45[CrossRef]
17. Campbell, K. S., Cooper, S., Dessing, M., Yates, S., and Buder, A. (1998) J. Immunol. 161, 1728-1737[Abstract/Free Full Text]
18. King, S. M., Dillman, J. F., 3rd, Benashski, S. E., Lye, R. J., Patel-King, R. S., and Pfister, K. K. (1996) J. Biol. Chem. 271, 32281-32287[Abstract/Free Full Text]
19. Nobis, P., Zibirre, R., Meyer, G., Kuhne, J., Warnecke, G., and Koch, G. (1985) J. Gen. Virol. 66, 2563-2569[Abstract/Free Full Text]
20. Aoki, J., Koike, S., Asou, H., Ise, I., Suwa, H., Tanaka, T., Miyasaka, M., and Nomoto, A. (1997) Exp. Cell Res. 235, 374-384[CrossRef][Medline] [Order article via Infotrieve]
21. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd. Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
22. Guan, K. L., and Dixon, J. E. (1991) Anal. Biochem. 192, 262-267[CrossRef][Medline] [Order article via Infotrieve]
23. Hannon, G. J., Demetrick, D., and Beach, D. (1993) Genes Dev. 7, 2378-2391[Abstract/Free Full Text]
24. Vojtek, A. B., Hollenberg, S. M., and Cooper, J. A. (1993) Cell 74, 205-214[CrossRef][Medline] [Order article via Infotrieve]
25. Cuconati, A., Xiang, W., Lahser, F., Pfister, T., and Wimmer, E. (1998) J. Virol. 72, 1297-1307[Abstract/Free Full Text]
26. Chien, C. T., Bartel, P. L., Sternglanz, R., and Fields, S. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 9578-9582[Abstract/Free Full Text]
27. Fields, S., and Song, O. (1989) Nature 340, 245-246[CrossRef][Medline] [Order article via Infotrieve]
28. Lader, E., Ha, H. S., O'Neill, M., Artzt, K., and Bennett, D. (1989) Cell 58, 969-979[CrossRef][Medline] [Order article via Infotrieve]
29. Watanabe, T. K., Fujiwara, T., Shimizu, F., Okuno, S., Suzuki, M., Takahashi, E., Nakamura, Y., and Hirai, Y. (1996) Cytogenet. Cell Genet. 73, 153-156[Medline] [Order article via Infotrieve]
30. Harrison, A., Olds-Clarke, P., and King, S. M. (1998) J. Cell Biol. 140, 1137-1147[Abstract/Free Full Text]
31. King, S. M., Barbarese, E., Dillman, J. F., 3rd, Benashski, S. E., Do, K. T., Patel-King, R. S., and Pfister, K. K. (1998) Biochemistry 37, 15033-15041[CrossRef][Medline] [Order article via Infotrieve]
32. Mou, T., Kraas, J. R., Fung, E. T., and Swope, S. L. (1998) FEBS Lett. 435, 275-281[CrossRef][Medline] [Order article via Infotrieve]
33. DiBella, L. M., Benashski, S. E., Tedford, H. W., Harrison, A., Patel-King, R. S., and King, S. M. (2001) J. Biol. Chem. 276, 14366-14373[Abstract/Free Full Text]
34. Yano, H., Lee, F. S., Kong, H., Chuang, J., Arevalo, J., Perez, P., Sung, C., and Chao, M. V. (2001) J. Neurosci. 21, RC125
35. Chuang, J. Z., Milner, T. A., and Sung, C. H. (2001) J. Neurosci. 21, 5501-5512[Abstract/Free Full Text]
36. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (eds) (1998) Current Protocols in Molecular Biology , John Wiley & Sons, New York
37. Mok, Y. K., Lo, K. W., and Zhang, M. (2001) J. Biol. Chem. 276, 14067-14074[Abstract/Free Full Text]
38. Kagami, O., Gotoh, M., Makino, Y., Mohri, H., Kamiya, R., and Ogawa, K. (1998) Gene 211, 383-386[CrossRef][Medline] [Order article via Infotrieve]
39. Holzbaur, E. L., and Vallee, R. B. (1994) Annu. Rev. Cell Biol. 10, 339-372[CrossRef]
40. Nathanson, N., and Langmuir, A. D. (1963) Am. J. Hyg. 78, 61-81
41. Sutter, R. W., Patriarca, P. A., Suleiman, A. J., Brogan, S., Malankar, P. G., Cochi, S. L., Al-, Ghassani, A. A., and el-Bualy, M. S. (1992) J. Infect. Dis. 165, 444-449[Medline] [Order article via Infotrieve]
42. Strebel, P. M., Ion-Nedelcu, N., Baughman, A. L., Sutter, R. W., and Cochi, S. L. (1995) N. Engl. J. Med. 332, 500-506[Abstract/Free Full Text]
43. Leon-Monzon, M. E., Illa, I., and Dalakas, M. C. (1995) Ann. N. Y. Acad. Sci. 753, 48-57[Abstract]
44. Tai, A. W., Chuang, J. Z., and Sung, C. H. (2001) J. Cell Biol. 153, 1499-1509[Abstract/Free Full Text]
45. Goldstein, L. S., and Yang, Z. (2000) Annu. Rev. Neurosci. 23, 39-71[CrossRef][Medline] [Order article via Infotrieve]
46. Raux, H., Flamand, A., and Blondel, D. (2000) J. Virol. 74, 10212-10216[Abstract/Free Full Text]
47. Jacob, Y., Badrane, H., Ceccaldi, P. E., and Tordo, N. (2000) J. Virol. 74, 10217-10222[Abstract/Free Full Text]
48. Ye, G. J., and Roizman, B. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 11002-11007[Abstract/Free Full Text]
49. Geraghty, R. J., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., and Spear, P. G. (1998) Science 280, 1618-1620[Abstract/Free Full Text]
50. Warner, M. S., Geraghty, R. J., Martinez, W. M., Montgomery, R. I., Whitbeck, J. C., Xu, R., Eisenberg, R. J., Cohen, G. H., and Spear, P. G. (1998) Virology 246, 179-189[CrossRef][Medline] [Order article via Infotrieve]
51. Strack, A. M., Sawyer, W. B., Hughes, J. H., Platt, K. B., and Loewy, A. D. (1989) Brain Res. 491, 156-162[CrossRef][Medline] [Order article via Infotrieve]
52. Loewy, A. D. (1995) in Viral Vectors (Kaplitt, G. , and Loewy, A. D., eds) , pp. 349-366, Academic Press, San Diego
53. Lentz, T. L., Burrage, T. G., Smith, A. L., Crick, J., and Tignor, G. H. (1982) Science 215, 182-184[Abstract/Free Full Text]
54. Murphy, F. A., and Bauer, S. P. (1974) Intervirology 3, 256-268[Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page